Researchers at PositiveID have created a prototype of a fully synthetic artificial glucose sensing system that can detect and respond to glucose levels in human plasma. The advance could play a key role in developing an artificial pancreas for patients with type 1 diabetes, the company's chairman and CEO said.

Related Summaries